chr21-43418250-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_173354.5(SIK1):c.1744+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00083 ( 0 hom., cov: 2)
Exomes 𝑓: 0.0011 ( 2 hom. )
Failed GnomAD Quality Control
Consequence
SIK1
NM_173354.5 intron
NM_173354.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.794
Genes affected
SIK1 (HGNC:11142): (salt inducible kinase 1) This gene encodes a serine/threonine protein kinase that contains a ubiquitin-associated (UBA) domain. The encoded protein is a member of the adenosine monophosphate-activated kinase (AMPK) subfamily of kinases that play a role in conserved signal transduction pathways. A mutation in this gene is associated with early infantile epileptic encephalopathy 30. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 21-43418250-C-T is Benign according to our data. Variant chr21-43418250-C-T is described in ClinVar as [Benign]. Clinvar id is 542711.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00112 (6/5376) while in subpopulation AMR AF= 0.0132 (2/152). AF 95% confidence interval is 0.00234. There are 2 homozygotes in gnomad4_exome. There are 4 alleles in male gnomad4_exome subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High AC in GnomAdExome4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIK1 | NM_173354.5 | c.1744+10G>A | intron_variant | ENST00000270162.8 | NP_775490.2 | |||
SIK1 | XM_011529474.3 | c.1597+10G>A | intron_variant | XP_011527776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIK1 | ENST00000270162.8 | c.1744+10G>A | intron_variant | 1 | NM_173354.5 | ENSP00000270162.6 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 6AN: 8408Hom.: 0 Cov.: 2 FAILED QC
GnomAD3 genomes
AF:
AC:
6
AN:
8408
Hom.:
Cov.:
2
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000237 AC: 58AN: 244370Hom.: 0 AF XY: 0.000181 AC XY: 24AN XY: 132698
GnomAD3 exomes
AF:
AC:
58
AN:
244370
Hom.:
AF XY:
AC XY:
24
AN XY:
132698
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00112 AC: 6AN: 5376Hom.: 2 Cov.: 0 AF XY: 0.00135 AC XY: 4AN XY: 2966
GnomAD4 exome
AF:
AC:
6
AN:
5376
Hom.:
Cov.:
0
AF XY:
AC XY:
4
AN XY:
2966
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000827 AC: 7AN: 8466Hom.: 0 Cov.: 2 AF XY: 0.000533 AC XY: 2AN XY: 3750
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
7
AN:
8466
Hom.:
Cov.:
2
AF XY:
AC XY:
2
AN XY:
3750
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 14, 2018 | - - |
Developmental and epileptic encephalopathy, 30 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at